|
| 36639314 | Corrigendum to: "An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs" [J Hepatol 75 (2021) 572-581]. | J Hepatol | 2023 |
| 37076803 | Predicting cholangiocarcinoma in primary sclerosing cholangitis: using artificial intelligence, clinical and laboratory data. | BMC Gastroenterol | 2023 |
| 36687160 | Environmental chemicals and endogenous metabolites in bile of USA and Norway patients with primary sclerosing cholangitis. | Exposome | 2023 |
| 34519176 | Induced Pluripotent Stem Cells From Subjects With Primary Sclerosing Cholangitis Develop a Senescence Phenotype Following Biliary Differentiation. | Hepatol Commun | 2022 |
| 35473391 | DNA methylation profile of liver tissue in end-stage cholestatic liver disease. | Epigenomics | 2022 |
| 34825528 | High-Resolution Exposomics and Metabolomics Reveals Specific Associations in Cholestatic Liver Diseases. | Hepatol Commun | 2022 |
| 33226645 | Bile Acid Profiles in Primary Sclerosing Cholangitis and Their Ability to Predict Hepatic Decompensation. | Hepatology | 2021 |
| 33794792 | Evaluation of circulating cell-free DNA in cholestatic liver disease using liver-specific methylation markers. | BMC Gastroenterol | 2021 |
| 34552080 | A scalable workflow to characterize the human exposome. | Nat Commun | 2021 |
| 34563121 | The PSC scientific community resource: an asset for multi-omics interrogation of primary sclerosing cholangitis. | BMC Gastroenterol | 2021 |
| 29742811 | Primary Sclerosing Cholangitis Risk Estimate Tool (PREsTo) Predicts Outcomes of the Disease: A Derivation and Validation Study Using Machine Learning. | Hepatology | 2020 |
| 31701542 | Studying the Exposome to Understand the Environmental Determinants of Complex Liver Diseases. | Hepatology | 2020 |
| 32914644 | Genome-wide resolution peripheral blood methylome profiling reveals signatures for cholestatic liver disease. | Epigenomics | 2020 |
| 32724082 | Single-cell mass cytometry on peripheral blood identifies immune cell subsets associated with primary biliary cholangitis. | Sci Rep | 2020 |
| 28779025 | Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis. | Gut | 2018 |
| 29881819 | External validation of the United Kingdom-primary biliary cholangitis risk scores of patients with primary biliary cholangitis treated with ursodeoxycholic acid. | Hepatol Commun | 2018 |
| 27992413 | Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease. | Nat Genet | 2017 |
| 28461130 | Doublecortin domain containing protein 2 (DCDC2) genetic variants in primary sclerosing cholangitis. | J Hepatol | 2017 |
| 28274849 | Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis. | Gastroenterology | 2017 |
| 28245345 | Variations in primary sclerosing cholangitis across the age spectrum. | J Gastroenterol Hepatol | 2017 |
| 28695657 | HLA haplotypes in primary sclerosing cholangitis patients of admixed and non-European ancestry. | HLA | 2017 |
| 26974007 | Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci. | Nat Genet | 2016 |
| 27062298 | Low incidence of primary biliary cirrhosis (PBC) in the first-degree relatives of PBC probands after 8 years of follow-up. | Liver Int | 2016 |
| 27002801 | Duration of Inflammatory Bowel Disease Is Associated With Increased Risk of Cholangiocarcinoma in Patients With Primary Sclerosing Cholangitis and IBD. | Am J Gastroenterol | 2016 |
| 25783671 | A comprehensive assessment of environmental exposures among 1000 North American patients with primary sclerosing cholangitis, with and without inflammatory bowel disease. | Aliment Pharmacol Ther | 2015 |
| 26276523 | Association between variants in inflammation and cancer-associated genes and risk and survival of cholangiocarcinoma. | Cancer Med | 2015 |
| 26676814 | Genome-Wide Association Studies in Primary Biliary Cirrhosis. | Semin Liver Dis | 2015 |
| 26394269 | International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways. | Nat Commun | 2015 |
| 25655558 | Association Between HLA Haplotypes and Increased Serum Levels of IgG4 in Patients With Primary Sclerosing Cholangitis. | Gastroenterology | 2015 |
| 24440215 | Reduced coffee consumption among individuals with primary sclerosing cholangitis but not primary biliary cirrhosis. | Clin Gastroenterol Hepatol | 2014 |
| 25057950 | Environmental factors in primary biliary cirrhosis. | Semin Liver Dis | 2014 |
| 24517468 | Small duct primary sclerosing cholangitis without inflammatory bowel disease is genetically different from large duct disease. | Liver Int | 2014 |
| 24317935 | Biochemical response to ursodeoxycholic acid predicts survival in a North American cohort of primary biliary cirrhosis patients. | J Gastroenterol | 2014 |
| 23490343 | Questionnaire based assessment of risk factors for primary biliary cirrhosis. | Dig Liver Dis | 2013 |
| 23603763 | Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis. | Nat Genet | 2013 |
| 22257840 | Association of primary biliary cirrhosis with variants in the CLEC16A, SOCS1, SPIB and SIAE immunomodulatory genes. | Genes Immun | 2012 |
| 22936693 | Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants. | Hum Mol Genet | 2012 |
| 22521342 | Extended analysis of a genome-wide association study in primary sclerosing cholangitis detects multiple novel risk loci. | J Hepatol | 2012 |
| 21151127 | Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci. | Nat Genet | 2011 |
| 21538286 | Genomics in the post-GWAS era. | Semin Liver Dis | 2011 |
| 21134112 | Genetic polymorphisms of matrix metalloproteinase 3 in primary sclerosing cholangitis. | Liver Int | 2011 |
| 20638243 | Update on the genetics and genomics of PBC. | J Autoimmun | 2010 |
| 20955967 | Primary biliary cirrhosis. | Best Pract Res Clin Gastroenterol | 2010 |
| 20639879 | Variants at IRF5-TNPO3, 17q12-21 and MMEL1 are associated with primary biliary cirrhosis. | Nat Genet | 2010 |
| 20578265 | Carriage of a tumor necrosis factor polymorphism amplifies the cytotoxic T-lymphocyte antigen 4 attributed risk of primary biliary cirrhosis: evidence for a gene-gene interaction. | Hepatology | 2010 |
| 19458352 | Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants. | N Engl J Med | 2009 |
| 19491853 | Common genetic variation and haplotypes of the anion exchanger SLC4A2 in primary biliary cirrhosis. | Am J Gastroenterol | 2009 |
| 18041714 | Interacting alleles of the coinhibitory immunoreceptor genes cytotoxic T-lymphocyte antigen 4 and programmed cell-death 1 influence risk and features of primary biliary cirrhosis. | Hepatology | 2008 |
| 18778710 | Primary biliary cirrhosis is associated with a genetic variant in the 3' flanking region of the CTLA4 gene. | Gastroenterology | 2008 |
| 18456185 | Genetics and genomics of primary biliary cirrhosis. | Clin Liver Dis | 2008 |